Therapeutic Advances in Drug Safety : Impact Factor & More
eISSN: 2042-0994pISSN: 2042-0986
Open AccessShare this on:
Key Metrics
CiteScore 
6.3
H-Index
42
Impact Factor
< 5
SJR
Q2Pharmacology (medical)
SNIP
1.67
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Therapeutic Advances in Drug Safety
Therapeutic Advances in Drug Safety Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2200 |
| Publication Time | 9 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Therapeutic Advances in Drug Safety ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Therapeutic Advances in Drug Safety
Safety of belimumab during pregnancy: associations with maternal and fetal or newborn adverse outcomes based on FAERS data
- 18 Jun 2026
- Therapeutic Advances in Drug Safety
Detection of clinically significant drug-drug interactions in serotonin syndrome: a multisource real-world data and pharmacovigilance study
- 16 Jun 2026
- Therapeutic Advances in Drug Safety
A descriptive, retrospective analysis of the quality of spontaneous adverse event reporting to the C\xf4te d\u2019Ivoire Pharmaceutical and Regulatory Authority and its impact on the causality assessment
- 8 Jun 2026
- Therapeutic Advances in Drug Safety
Absence of pharmacovigilance signals for bleeding events associated with warfarin-SSRI drug interactions: a comparative analysis of FAERS and CVARD databases
- 4 Jun 2026
- Therapeutic Advances in Drug Safety
Comparison of pharmacovigilance and mechanism analysis of the vascular toxicity caused by platin-based chemotherapy: integration of FAERS analysis, network pharmacology, and endothelial validation
- 3 Jun 2026
- Therapeutic Advances in Drug Safety
Pharmacogenetic variants in pharmacokinetic and pharmacodynamic pathways and clinical factors associated with bleeding risk in Thai patients receiving rivaroxaban: a case\u2013control study
- 29 May 2026
- Therapeutic Advances in Drug Safety
Safety of belimumab during pregnancy: associations with maternal and fetal or newborn adverse outcomes based on FAERS data
- 18 Jun 2026
- Therapeutic Advances in Drug Safety
Detection of clinically significant drug-drug interactions in serotonin syndrome: a multisource real-world data and pharmacovigilance study
- 16 Jun 2026
- Therapeutic Advances in Drug Safety
A descriptive, retrospective analysis of the quality of spontaneous adverse event reporting to the C\xf4te d\u2019Ivoire Pharmaceutical and Regulatory Authority and its impact on the causality assessment
- 8 Jun 2026
- Therapeutic Advances in Drug Safety
Absence of pharmacovigilance signals for bleeding events associated with warfarin-SSRI drug interactions: a comparative analysis of FAERS and CVARD databases
- 4 Jun 2026
- Therapeutic Advances in Drug Safety
Comparison of pharmacovigilance and mechanism analysis of the vascular toxicity caused by platin-based chemotherapy: integration of FAERS analysis, network pharmacology, and endothelial validation
- 3 Jun 2026
- Therapeutic Advances in Drug Safety
Pharmacogenetic variants in pharmacokinetic and pharmacodynamic pathways and clinical factors associated with bleeding risk in Thai patients receiving rivaroxaban: a case\u2013control study
- 29 May 2026
- Therapeutic Advances in Drug Safety
FAQs on Therapeutic Advances in Drug Safety
How long has Therapeutic Advances in Drug Safety been actively publishing? 
What is the publishing frequency of Therapeutic Advances in Drug Safety?
How many articles did Therapeutic Advances in Drug Safety publish last year?
What is the eISSN & pISSN for Therapeutic Advances in Drug Safety?
What is Citescore for Therapeutic Advances in Drug Safety?
What is the H Index for Therapeutic Advances in Drug Safety ?
What is SNIP score for Therapeutic Advances in Drug Safety?
What is the SJR for Therapeutic Advances in Drug Safety?
Who is the publisher of Therapeutic Advances in Drug Safety?
